Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Serena J Silver
Affiliation
ORCID
Career Start Year
2003
Papers
28
H Index
26
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
33446805
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms.
Sci Rep
2021
31439712
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers.
Mol Cancer Ther
2019
30380416
TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer.
Cell Rep
2018
30247463
Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening.
J Vis Exp
2018
29195078
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.
Cell
2017
28753431
Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.
Cell
2017
24584072
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.
Nat Genet
2014
24440720
ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state.
Cell Rep
2014
22863010
Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL.
Cell
2012
21706014
A public genome-scale lentiviral expression library of human ORFs.
Nat Methods
2011
21633165
The JAK2/STAT3 signaling pathway is required for growth of CD44âºCD24â» stem cell-like breast cancer cells in human tumors.
J Clin Invest
2011
20601955
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.
Nat Genet
2010
20126544
CK1epsilon is required for breast cancers dependent on beta-catenin activity.
PLoS One
2010
20064372
A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection.
Cell
2009
19490892
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.
Cell
2009
19573809
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
Cancer Cell
2009
19800574
Proteomic and genetic approaches identify Syk as an AML target.
Cancer Cell
2009
19188593
Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning.
Proc Natl Acad Sci U S A
2009
19847166
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.
Nature
2009
18794900
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.
Nature
2008
17989227
Functional screening identifies miR-315 as a potent activator of Wingless signaling.
Proceedings of the National Academy of Sciences of the United States of America
2007
16964256
Evidence of off-target effects associated with long dsRNAs in Drosophila melanogaster cell-based assays.
Nature Methods
2006
15734575
New vision from Eyes absent: transcription factors as enzymes.
Trends in Genetics
2005
15802522
Using Drosophila to decipher how mutations associated with human branchio-oto-renal syndrome and optical defects compromise the protein tyrosine phosphatase and transcriptional functions of eyes absent.
Genetics
2005
15590745
Signaling circuitries in development: insights from the retinal determination gene network.
Development (Cambridge)
2005
15286999
New class of Son-of-sevenless (Sos) alleles highlights the complexities of Sos function.
Genesis
2004
14628053
The transcription factor Eyes absent is a protein tyrosine phosphatase.
Nature
2003
12917324
Functional dissection of eyes absent reveals new modes of regulation within the retinal determination gene network.
Molecular and Cellular Biology
2003
1 - 28 of 28
Column Actions
Search
Recommended Authors
Collaborators
David E Root
Broad Institute of Harvard and MIT
Co-authored papers
15
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers
9
Jesse S Boehm
Broad Institute of Harvard and MIT
Co-authored papers
7
Ian F Dunn
Co-authored papers
5
Anna C Schinzel
Co-authored papers
5
William R Sellers
Co-authored papers
4
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers
4
Matthew Meyerson
Broad Institute
Co-authored papers
3
Anne E Carpenter
Broad Institute of MIT and Harvard
Co-authored papers
3
Kimberly Stegmaier
Dana-Farber Cancer Institute
Co-authored papers
3
Craig H Mermel
Co-authored papers
3
Tyler Jacks
Co-authored papers
3
David M Sabatini
Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology
Co-authored papers
3
Pablo Tamayo
University of California San Diego
Co-authored papers
3
Stuart L Schreiber
Broad Institute
Co-authored papers
2
Ron Firestein
Co-authored papers
2
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers
2
Federica Piccioni
Co-authored papers
2
Milan G Chheda
Co-authored papers
2
Barbara A Weir
Janssen Research and Development LLC
Co-authored papers
2
James E Bradner
Co-authored papers
2
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers
2
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers
2
Norbert Perrimon
Co-authored papers
2
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers
2
Jordi Barretina
Co-authored papers
2
Mark-Anthony Bray
Co-authored papers
2
Paul A Clemons
Broad Institute
Co-authored papers
2
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Co-authored papers
2
Jill P Mesirov
University of California San Diego
Co-authored papers
1
1 - 30